Keywords

• Ganirelix
• Ganirelix Acetate
• 123246-29-7

Quick Details

• ProName: Ganirelix Acetate
• CasNo: 123246-29-7
• Molecular Formula: C80h113cln18o13
• Appearance: white powder
• Application: Ganirelix Acetate
• DeliveryTime: 5 days
• PackAge: Vial or customized
• Port: Shanghai, Beijing, Shenzhen etc.
• ProductionCapacity: 100 Kilogram/Month
• Purity: 99%
• Storage: 2-8℃ sealed and away from light
• Transportation: Ocean and air shipping
• LimitNum: 10 Milligram
• Related Substances: Effective ingredients >99%
• Residue on Ignition: 0.1
• Heavy Metal: 0
• Valid Period: 3 years

Superiority

GMP Manafacturer

High Purity

Competitive Price

Short Delivery Time

One of the standout features of our Ganirelix Acetate is its rapid onset of action. Once administered, it quickly exerts its inhibitory effect on LH secretion, providing a reliable and timely solution to prevent premature ovulation. This rapid efficacy is especially valuable in the fast - paced and time - sensitive field of ART, where any delay in preventing the LH surge can lead to treatment failure. Our product ensures that healthcare providers can have full confidence in the hormonal regulation process, making it an essential component of successful fertility treatment regimens.

Jixianglong has peptide drug production workshop and pilot workshop for personalized cancer neoantigen peptide vaccine which approved by GMP standard. More than 300 sets advanced instruments for production and testing, such as Solid phase synthesizer, Preparative liquid chromatograph, Freeze dryer, High performance liquid chromatograph etc.

Details

Ganirelix acetate CAS No. 123246-29-7
Ganirelix acetate is a synthetic decapeptide with high antagonist activity and the first GnRH antagonist to be marketed. It is approved for the suppression of LH surges in women who are undergoing ovarian hyperstimulation fertility treatment.

Company Profile 

Founded in 2011, Harbin Jixianglong Biotech Co., Ltd. is a is a professional high-tech company specializing in R&D and production of polypeptide pharmaceuticals. Our advanced industry chain occupied in R&D, approbation and industrialization of peptides API and preparation.
Jixianglong has peptide drug production workshop and pilot workshop for personalized cancer neoantigen peptide vaccine which approved by GMP standard. More than 300 sets advanced instruments for production and testing, such as Solid phase synthesizer, Preparative liquid chromatograph, Freeze dryer, High performance liquid chromatograph etc.
Jixianglong has 10 APIs production approvals, 16 invention patents achieved, including 5 compound patents.